{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:30:38Z","timestamp":1789205438290,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ejpn.2023.11.013","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T11:58:23Z","timestamp":1701691103000},"page":"69-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Neurological presentations of inborn errors of purine and pyrimidine metabolism"],"prefix":"10.1016","volume":"48","author":[{"given":"Marie-C\u00e9cile","family":"Nassogne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Marie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7223-2706","authenticated-orcid":false,"given":"Joseph P.","family":"Dewulf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2023.11.013_bib1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0002-9343(64)90104-4","article-title":"A\u00a0familial disorder of uric acid metabolism and central nervous system function","volume":"36","author":"Lesch","year":"1964","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejpn.2023.11.013_bib2","series-title":"Inborn Metabolic Diseases Diagnosis and Treatment","first-page":"587","article-title":"Disorders of purine and pyrimidine metabolism","author":"Marie","year":"2022"},{"key":"10.1016\/j.ejpn.2023.11.013_bib3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s10545-014-9731-6","article-title":"Inborn errors of purine metabolism: clinical update and therapies","volume":"37","author":"Balasubramaniam","year":"2014","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ejpn.2023.11.013_bib4","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10545-014-9742-3","article-title":"Inborn errors of pyrimidine metabolism: clinical update and therapy","volume":"37","author":"Balasubramaniam","year":"2014","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ejpn.2023.11.013_bib5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ymgme.2021.12.016","article-title":"Disorders of purine biosynthesis metabolism","volume":"136","author":"Dewulf","year":"2022","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.ejpn.2023.11.013_bib6","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ajhg.2010.02.024","article-title":"PRPS1 mutations: four distinct syndromes and potential treatment","volume":"86","author":"de Brouwer","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejpn.2023.11.013_bib7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13023-014-0190-9","article-title":"Expanding the phenotype of PRPS1 syndromes in females: neuropathy, hearing loss and retinopathy","volume":"9","author":"Almoguera","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ejpn.2023.11.013_bib8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/humu.23349","article-title":"Missense variants in the X-linked gene PRPS1 cause retinal degeneration in females","volume":"39","author":"Fiorentino","year":"2018","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ejpn.2023.11.013_bib9","article-title":"Co-therapy with S-adenosylmethionine and nicotinamide riboside improves t-cell survival and function in Arts Syndrome (PRPS1 deficiency)","volume":"26","author":"Lenherr","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ejpn.2023.11.013_bib10","series-title":"GeneReviews\u00ae [Internet]","first-page":"1993","article-title":"Phosphoribosylpyrophosphate synthetase superactivity","author":"de Brouwer","year":"2008"},{"key":"10.1016\/j.ejpn.2023.11.013_bib11","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1093\/hmg\/ddz237","article-title":"PAICS deficiency, a new defect of de novo purine synthesis resulting in multiple congenital anomalies and fatal outcome","volume":"28","author":"Pelet","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejpn.2023.11.013_bib12","first-page":"1058","article-title":"An infantile autistic syndrome characterised by the presence of succinylpurines in body fluids","volume":"2","author":"Jaeken","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.ejpn.2023.11.013_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13023-021-01731-6","article-title":"Clinical and molecular characterization of patients with adenylosuccinate lyase deficiency","volume":"16","author":"Mastrogiorgio","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ejpn.2023.11.013_bib14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ajmg.a.62999","article-title":"Anticipatory banking of samples enables diagnosis of adenylosuccinase deficiency following molecular autopsy in an infant with vacuolating leukoencephalopathy","volume":"191","author":"Sitaram","year":"2023","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejpn.2023.11.013_bib15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/jmg.39.6.440","article-title":"Towards a suggestive facial dysmorphism in adenylosuccinate lyase deficiency?","volume":"39","author":"Holder-Espinasse","year":"2002","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.ejpn.2023.11.013_bib16","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/0883073811424465","article-title":"Neurologic presentation, diagnostics, and therapeutic insights in a severe case of adenylosuccinate lyase deficiency","volume":"27","author":"Jurecka","year":"2012","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.ejpn.2023.11.013_bib17","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1086\/421475","article-title":"AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC","volume":"74","author":"Marie","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejpn.2023.11.013_bib18","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/jimd.12274","article-title":"AICA-ribosiduria due to ATIC deficiency: delineation of the phenotype with three novel cases, and long-term update on the first case","volume":"43","author":"Ramond","year":"2020","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ejpn.2023.11.013_bib19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ajmg.a.63036","article-title":"Expanding the spectrum of clinical severity of AICA-ribosiduria: report of two siblings with mild phenotype caused by a novel pathogenic variant in ATIC gene","volume":"191","author":"Galli","year":"2023","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejpn.2023.11.013_bib20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41431-018-0098-2","article-title":"Clinical and genetic spectrum of AMPD2-related pontocerebellar hypoplasia type 9","volume":"26","author":"Kort\u00fcm","year":"2018","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ejpn.2023.11.013_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10048-022-00706-4","article-title":"Delineating the phenotype and genetic basis of AMPD2-related pontocerebellar hypoplasia","volume":"24","author":"Gilboa","year":"2023","journal-title":"Neurogenetics"},{"key":"10.1016\/j.ejpn.2023.11.013_bib22","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1212\/WNL.0000000000004542","article-title":"Teaching NeuroImages: figure of 8: the clue to the diagnosis of AMPD2 pontocerebellar hypoplasia (PCH9)","volume":"89","author":"Severino","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2023.11.013_bib23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/brain\/awq013","article-title":"Attenuated variants of Lesch-Nyhan disease","volume":"133","author":"Jinnah","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2023.11.013_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41436-018-0053-1","article-title":"Macrocytic anemia in Lesch-Nyhan disease and its variants","volume":"21","author":"Cakmakli","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ejpn.2023.11.013_bib25","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1212\/WNL.0000000000001128","article-title":"Brain white matter volume abnormalities in Lesch-Nyhan disease and its variants","volume":"84","author":"Schretlen","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2023.11.013_bib26","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1093\/brain\/awac439","article-title":"Metabolic patterns in brain 18F-fluorodeoxyglucose PET relate to aetiology in paediatric dystonia","volume":"146","author":"Tsagkaris","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2023.11.013_bib27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/21678707.2019.1652597","article-title":"Current understanding of Lesch-Nyhan disease and potential therapeutic targets","volume":"7","author":"Torres","year":"2019","journal-title":"Expert Opinion on Orphan Drugs"},{"key":"10.1016\/j.ejpn.2023.11.013_bib28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s10143-023-01950-4","article-title":"Deep brain stimulation in Lesch-Nyhan syndrome: a systematic review","volume":"46","author":"Deng","year":"2023","journal-title":"Neurosurg. Rev."},{"key":"10.1016\/j.ejpn.2023.11.013_bib29","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/ana.24119","article-title":"Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymia","volume":"75","author":"Chen","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejpn.2023.11.013_bib30","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/mdc3.13796","article-title":"Scoping review on ADCY5-related movement disorders","volume":"10","author":"Menon","year":"2023","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.ejpn.2023.11.013_bib31","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/mdc3.13796","article-title":"Scoping review on ADCY5-related movement disorders","volume":"10","author":"Menon","year":"2023","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.ejpn.2023.11.013_bib32","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ana.24496","article-title":"Recessive ITPA mutations cause an early infantile encephalopathy","volume":"78","author":"Kevelam","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejpn.2023.11.013_bib33","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/humu.24326","article-title":"Clinico-radiological features, molecular spectrum, and identification of prognostic factors in developmental and epileptic encephalopathy due to inosine triphosphate pyrophosphatase (ITPase) deficiency","volume":"43","author":"Scala","year":"2022","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ejpn.2023.11.013_bib34","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/s41436-020-0933-z","article-title":"Expanding the clinical and genetic spectrum of CAD deficiency: an epileptic encephalopathy treatable with uridine supplementation","volume":"22","author":"Rymen","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.ejpn.2023.11.013_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.12667","article-title":"Beyond genetics: deciphering the impact of missense variants in CAD deficiency","author":"Del Ca\u00f1o-Ochoa","year":"2023","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ejpn.2023.11.013_bib36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/ng.499","article-title":"Exome sequencing identifies the cause of a mendelian disorder","volume":"42","author":"Ng","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejpn.2023.11.013_bib37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ymgme.2016.06.008","article-title":"Elevated plasma dihydroorotate in Miller syndrome: biochemical, diagnostic and clinical implications, and treatment with uridine","volume":"119","author":"Duley","year":"2016","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.ejpn.2023.11.013_bib38","first-page":"49","article-title":"Dihydropyrimidine dehydrogenase deficiency: metabolic disease or biochemical phenotype?","volume":"37","author":"Fleger","year":"2017","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ejpn.2023.11.013_bib39","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ymgme.2017.10.003","article-title":"Dihydropyrimidinase deficiency in four East Asian patients due to novel and rare DPYS mutations affecting protein structural integrity and catalytic activity","volume":"122","author":"Nakajima","year":"2017","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.ejpn.2023.11.013_bib40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ymgme.2022.07.011","article-title":"The relationship between beta-ureidopropionase deficiency due to UPB1 variants and human phenotypes is uncertain","volume":"137","author":"Righetti","year":"2022","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.ejpn.2023.11.013_bib41","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s10545-014-9682-y","article-title":"Clinical, biochemical and molecular analysis of 13 Japanese patients with \u03b2-ureidopropionase deficiency demonstrates high prevalence of the c.977G > A (p.R326Q) mutation","volume":"37","author":"Nakajima","year":"2014","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ejpn.2023.11.013_bib42","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41431-019-0540-0","article-title":"Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of DPYD and fuoropyrimidines","volume":"28","author":"Lunenburg","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ejpn.2023.11.013_bib43","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00280-009-1071-0","article-title":"Contribution of dihydropyrimidinase gene alterations to the development of serious toxicity in fuoropyrimidine-treated cancer patients","volume":"65","author":"Fidlerova","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejpn.2023.11.013_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.101197","article-title":"Implementation of dihydropyrimidine dehydrogenase deficiency testing in Europe","volume":"8","author":"de With","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.ejpn.2023.11.013_bib45","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ana.24550","article-title":"ADSSL1 mutation relevant to autosomal recessive adolescent onset distal myopathy","volume":"79","author":"Park","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejpn.2023.11.013_bib46","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41436-019-0680-1","article-title":"The genomic and clinical landscape of fetal akinesia","volume":"22","author":"Pergande","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.ejpn.2023.11.013_bib47","doi-asserted-by":"crossref","first-page":"e1500","DOI":"10.1212\/WNL.0000000000010237","article-title":"ADSSL1 myopathy is the most common nemaline myopathy in Japan with variable clinical features","volume":"95","author":"Saito","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2023.11.013_bib48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-0035-1547341","article-title":"Hereditary orotic aciduria with epilepsy and without megaloblastic anemia","volume":"46","author":"Grohmann","year":"2015","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ejpn.2023.11.013_bib49","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archpedi.1967.02090210147020","article-title":"Megaloblastic anemia and orotic aciduria. A hereditary disorder of pyrimidine metabolism responsive to uridine","volume":"113","author":"Haggard","year":"1967","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.ejpn.2023.11.013_bib50","first-page":"45","article-title":"Purine nucleoside phosphorylase deficiency","volume":"3","author":"Markert","year":"1991","journal-title":"Immunodefic. Rev."},{"key":"10.1016\/j.ejpn.2023.11.013_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2022.104428","article-title":"Combined immunodeficiency due to purine nucleoside phosphorylase deficiency: outcome of three patients","volume":"65","author":"Torun","year":"2022","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.ejpn.2023.11.013_bib52","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ymgme.2022.02.007","article-title":"Inborn errors of purine and pyrimidine metabolism: a guide to diagnosis","volume":"136","author":"Jurecka","year":"2022","journal-title":"Mol. Genet. Metabol."}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379823001836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379823001836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:42:01Z","timestamp":1761072121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379823001836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":52,"alternative-id":["S1090379823001836"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2023.11.013","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurological presentations of inborn errors of purine and pyrimidine metabolism","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2023.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}